SILVER LAKE RESEARCH CORPORATION
Medtech · Private
Lateral flow immunoassay test kit for rapid detection of β-lactam antibiotic resistance in urine samples
- Grants
- $4.9M
- 9 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $5.9M
- 11 awards · Defense, Homeland Security, Health and Human S
- #107 of 4531 in medtech
- Patents
- 6
- 1 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2006200820102012201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · Antibody And Hand Held Assays | $184,186 | |
| Federal contract | Department of Homeland Security · Igf::ct::igf Description: The Purpose Of Department Of Homeland Security Contract HSHQDC-13-C-00097 Is To Provide $200,129 In Funding To Silver Lake Research Corporation (slrc) For The Performance Of Hyper-specific Monoclonal Antibodies (mabs) Tests Against Biothreat Agents. Note 1: This Is A Firm-fixed-price (ffp) Contract. All Work Shall Be Performed In Accordance With The Detailed Statement Of Work Attached To This Contract As Attachment 1. | $200,129 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid LFIA blood test for SCD using highly specific monoclonal antibodies | $221,502 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of Faster, Lower-Cost, High-Sensitivity Immunoassay for Specific Determination of Glucagon Using EAP-derived Monoclonal Antibodies | $223,487 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Hyperspecific Monoclonal Antibodies And Lateral Flow Assays | $246,000 | |
| Federal contract | Department of Homeland Security · Igf::cl,ct::igf Research And Development Services For The Department Of Homeland Security, Science And Technology Directorate, Chemical And Biological Defense Division For The Creation And Validation Of Small Molecule Select Agent Toxin Detection Assays. | $326,147 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | $994,558 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of Faster, Lower-Cost, High-Sensitivity Immunoassay for Specific Determination of Glucagon Using EAP-derived Monoclonal Antibodies | $220,101 | |
| Federal contract | Department of Homeland Security · Igf::cl,ct::igf Research And Development Services For The Department Of Homeland Security, Science And Technology Directorate, Chemical And Biological Defense Division To Include The Generation Of New Monoclonal Antibodies (mabs) Reactive With This Group Of Toxins Using The Contractor's Proprietary Eap Immunization System, The Validation And Characterization Of These Mabs In Conjunction With Dhs, And, As An Option, The Development And Validation Of Easy-to-use, Rapid Lfa Tests For On-site Deter | $700,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid LFIA blood test for SCD using highly specific monoclonal antibodies | $500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | $989,678 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid LFIA blood test for SCD using highly specific monoclonal antibodies | $500,000 | |
| Federal contract | Department of Health and Human Services · Antibodies | $25,085 | |
| Federal grant | Department of Health and Human Services · Phase II · Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | $975,121 | |
| Federal contract | Department of Health and Human Services · 068,EAP-DERIVED Monoclonal Antibodies For Phenotyping Immune Cells Of Animal Models Of Disease | $599,999 | |
| Federal contract | Department of Homeland Security · New Contract Firm-fixed Price For Rapid Detection Of High-priority Foreign Animal Pathogens Using Eap-derived Hyperspecific Monoclonal Antibodies. | $1,656,990 | |
| Federal contract | Department of Health and Human Services · Eap-derived Monoclonal Antibodies For Phenotyping Guinea Pig Immune Cells. | $600,000 | |
| Federal contract | Department of Health and Human Services · Eap-derived Monoclonal Antibodies For "wish List" Hamster Immune Targets Involved In Cell Activation. | $600,000 | |
| Federal contract | Department of Health and Human Services · SBIR Topic 118: Reagents For Immunologic Analysis Of Non-mammalian And Underrepresented Mammalian Models. | $750,000 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 104 | BAEBIES, INC. | $5.9M | $77M |
| 105 | Lignamed, LLC | $5.9M | — |
| 106 | TIGER TECH SOLUTIONS INC | $5.9M | — |
| 107 | SILVER LAKE RESEARCH CORPORATION | $5.9M | — |
| 108 | LIBERATING TECHNOLOGIES INC | $5.9M | — |
| 109 | NEURO KINETICS, INC. | $5.8M | $1.5M |
| 110 | OURARING INC | $5.8M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods of Detection of Antibiotic-Resistant Bacteriaapplication
- Biomarkers For Detecting The Presence Of Bacteriagranted
- Methods Of Detection Of Antibiotic-resistant Bacteriaapplication
- Methods Of Detection Of Antibiotic-resistant Bacteriaapplication
- Biomarkers For Detecting The Presence Of Bacteriaapplication
- Chromatographic Test Strips For One Or More Analytesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.